Abortion News and Research RSS Feed - Abortion News and Research

U.S. District Court enters verdict in favor of faith-based car dealership in challenge to HHS abortion pill mandate

Today, a U.S. District Court entered a final judgment in favor of the family owned, faith-based car dealership in South Charleston, WV, Joe Holland Chevrolet and its principal owner Joseph B. Holland, Jr. in their legal challenge against the federal government's abortion pill mandate. [More]
DNMT1 gene essential to maintain breast and cancer stem cells

DNMT1 gene essential to maintain breast and cancer stem cells

The gene and hormone soup that enables women to breastfeed their newborns also can be a recipe for breast cancer, particularly when the first pregnancy is after age 30. [More]
BP monitoring essential for early diagnosis, management of hypertensive disorders in pregnancy

BP monitoring essential for early diagnosis, management of hypertensive disorders in pregnancy

Accurate blood pressure measurement (BP) is fundamental to the early diagnosis of hypertensive disorders in pregnancy, says a review published 1 April, 2015, in The Obstetrician & Gynaecologist (TOG). [More]
Two scientific studies may change clinical practices regarding medical abortions, miscarriages

Two scientific studies may change clinical practices regarding medical abortions, miscarriages

Two scientific studies led by researchers at Sweden's Karolinska Institutet are expected to form the basis of new international recommendations for the treatment of medical abortions and miscarriages. [More]
FDA approves LILETTA (levonorgestrel-releasing intrauterine system) to prevent pregnancy

FDA approves LILETTA (levonorgestrel-releasing intrauterine system) to prevent pregnancy

Actavis plc, a leading global specialty pharmaceutical company, and Medicines360, a nonprofit women's health pharmaceutical company, today announced the approval of LILETTA (levonorgestrel-releasing intrauterine system) by the U.S. Food and Drug Administration for use by women to prevent pregnancy for up to three years. [More]
Standard cleaning procedures in retail delis may not eradicate Listeria pathogen, study shows

Standard cleaning procedures in retail delis may not eradicate Listeria pathogen, study shows

Purdue University research shows that standard cleaning procedures in retail delis may not eradicate Listeria monocytogenes bacteria, which can cause a potentially fatal disease in people with vulnerable immune systems. [More]

Study documents concerns relating to tissue donation

When donating blood, plasma, human tissue or any other bodily sample for medical research, most people might not think about how it's being used. But if you were told, would you care? [More]
Multiple micronutrient supplement during pregnancy reduces pre-term births, increases infant birth weight

Multiple micronutrient supplement during pregnancy reduces pre-term births, increases infant birth weight

A multivitamin given daily to pregnant women in rural Bangladesh reduced pre-term births, increased infant birth weight and resulted in healthier babies overall, according to the large randomized trial conducted by Johns Hopkins Bloomberg School of Public Health researchers. [More]
Three-drug regimen taken during pregnancy prevents mother-to-child HIV transmission

Three-drug regimen taken during pregnancy prevents mother-to-child HIV transmission

For HIV-infected women in good immune health, taking a three-drug regimen during pregnancy prevents mother-to-child HIV transmission more effectively than taking one drug during pregnancy, another during labor and two more after giving birth, an international clinical trial has found. [More]
Viewpoints: Abortion and birth control issues in N.C. Senate race; replacing Obamacare; cancellations

Viewpoints: Abortion and birth control issues in N.C. Senate race; replacing Obamacare; cancellations

But on Wednesday in Charlotte, Kay Hagan stood without hesitation next to Janet Colm, chief executive of the Planned Parenthood Action Fund of Central North Carolina, and proudly bashed her opponent, Thom Tillis, for reducing women's rights on abortion and birth control. [More]
Longer Looks: An Alabama Judge's Dismantling Of Roe V. Wade; The Mystery Of Enterovirus; Mutating Ebola

Longer Looks: An Alabama Judge's Dismantling Of Roe V. Wade; The Mystery Of Enterovirus; Mutating Ebola

In the nine years Parker has now served on the court, he has made the most of his opportunities. Child custody disputes, for instance, have made good occasions to expound on the role of religion in parental rights. [More]
Viewpoints: 'Blunders' on Ebola; McConnell's strange logic on Obamacare; temporary victory for Texas women

Viewpoints: 'Blunders' on Ebola; McConnell's strange logic on Obamacare; temporary victory for Texas women

The point of this is not to flog Presbyterian, though a few lashes might help snap [Daniel] Varga and other administrators back to reality. [More]
A day after the high court blocked a Texas law restricting abortions, shuttered clinics prepared to reopen

A day after the high court blocked a Texas law restricting abortions, shuttered clinics prepared to reopen

Some Texas abortion clinics resumed scheduling patients for abortions after the Supreme Court's intervention. However, they did so knowing the legal challenges are not over. [More]

Viewpoints: Health law undercuts labor markets; the surprising foes on Calif. Prop 45

A report out today from the Republican staff of the Senate Budget Committee highlights a critical point about Obamacare: The law's negative effect on labor markets helps explain why it will increase deficits by $131 billion over the next 10 years. This finding stands in stark contrast to Democrats' repeated assertions that the law will reduce the deficit. The public dialogue on Obamacare has thus far largely focused on how the law affects premiums and limits access to certain health insurance plans or doctors. [More]
High court allows Texas abortion clinics to stay open

High court allows Texas abortion clinics to stay open

The Supreme Court's order, staying a decision of the U.S. Court of Appeals for the 5th Circuit, will allow more than a dozen clinics to resume operations at least temporarily, until a legal challenge has been settled. [More]
Viewpoints: Health law opposition not propelling GOP; keep politics out of the fight against Ebola

Viewpoints: Health law opposition not propelling GOP; keep politics out of the fight against Ebola

As recently as April, Obamacare was going to be the silver bullet for Republicans in this year's midterm elections. The leader of conservative advocacy group Americans for Prosperity said his plan was to make Obamacare "the No. 1 issue in the country." Senate Minority Leader Mitch McConnell, R-Ky., declared that the law would be "a huge disaster in 2014" and the deciding factor in November. Well, that was then. Now, three weeks from Election Day, some GOP challengers trying to knock off Democratic incumbent senators have scaled back their anti-Obamacare ads in favor of new targets such as the economy and national security (10/13). [More]

Opponents attempt to outlaw abortion state-by-state

The numbers have changed little over the decades: A majority of Americans support abortion. But across the country, the antiabortion movement has recorded major success in the last four years, part of a well-funded national strategy to legislate abortion out of existence state by state. Legislatures, many stocked with new Republican majorities, have passed laws that, if upheld, would drastically reduce access to abortion for millions of women (Semuels and La Ganga, 10/12). [More]
State highlights: Blue Cross Blue Shield dominant in Texas

State highlights: Blue Cross Blue Shield dominant in Texas

A selection of health policy stories from Texas, New Jersey, Connecticut, Georgia, Missouri and New Mexico. [More]

Abortion ads play big in N.H. and Colo. Senate campaigns

As the senatorial campaigns in New Hampshire and Colorado continue to highlight candidate positions on abortion, the rhetoric over the health law calms a bit. [More]
BGI issued patent for non-invasive prenatal genetic test technology

BGI issued patent for non-invasive prenatal genetic test technology

The European Patent Office has issued patent number EP2561103B1 for invention to BGI for its independently researched non-invasive prenatal genetic test (NIPT) technology. This technology has been developed by BGI in connection with the provision of its market leading NIPT, the NIFTY test. [More]
Advertisement
Advertisement